SARS-CoV-2 infection in microglia and its sequelae: What do we know so far?
Open Access
- 12 October 2024
- journal article
- research article
- Published by Elsevier in Brain, Behavior, & Immunity - Health
- Vol. 42, 100888
Abstract
No abstract availableKeywords
This publication has 87 references indexed in Scilit:
- Epigenetic memory of coronavirus infection in innate immune cells and their progenitorsCell, 2023
- Human microglial models to study host–virus interactionsExperimental Neurology, 2023
- SARS-CoV-2 infects neurons and induces neuroinflammation in a non-human primate model of COVID-19Cell Reports, 2022
- Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infectionsBrain, Behavior, and Immunity, 2022
- Global Incidence of Neurological Manifestations Among Patients Hospitalized With COVID-19—A Report for the GCS-NeuroCOVID Consortium and the ENERGY ConsortiumJAMA Network Open, 2021
- Effects of COVID-19 on the Nervous SystemCell, 2020
- SARS-CoV-2 ORF3b Is a Potent Interferon Antagonist Whose Activity Is Increased by a Naturally Occurring Elongation VariantCell Reports, 2020
- Microglia Biology: One Century of Evolving ConceptsCell, 2019
- Development and characterization of a human microglia cell model of HIV-1 infectionJournal of NeuroVirology, 2016
- Human microglial cells: Characterization in cerebral tissue and in primary culture, and study of their susceptibility to HIV‐1 infectionAnnals of Neurology, 1991